Although the mechanism is unclear, previous studies reporting the association between cardiovascular disease and COPD suggested the contribution of pulmonary vascular congestion or proinflammatory molecules, including angiotensin 2, in cardiovascular disease to the development of AFL22. This evidence concerns the gene AGT and cardiovascular disorder.